China Pharma Holdings logo
China Pharma Holdings CPHI
$ 0.2 5.73%

Quarterly report 2024-Q3
added 11-13-2024

report update icon

China Pharma Holdings Income Statement 2011-2024 | CPHI

Annual Income Statement China Pharma Holdings

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

1.25 M 368 K 2.21 M 30.9 M 18.3 M 12.6 M 14.8 M 10.9 M 6.1 M 13.1 M 18.7 M 10.9 M 33 M

Shares

3.38 M 1.05 M 4.61 M 43.6 M 43.6 M 43.6 M 43.6 M 43.6 M 43.6 M 43.6 M 43.6 M 43.6 M 43.5 M

Historical Prices

0.37 0.35 0.48 0.45 0.24 0.26 0.18 0.26 0.16 0.3 0.35 0.2 0.67

Net Income

-3.08 M -3.97 M -3.4 M -2.87 M -20.7 M -10.8 M -19.3 M -9.18 M -15.4 M -26 M -20 M 4.62 M 19.3 M

Revenue

7.01 M 8.1 M 9.64 M 10.9 M 10.9 M 12.3 M 13.2 M 15.6 M 20.4 M 24.9 M 32.8 M 54.5 M 81.2 M

Cost of Revenue

7.29 M 8.6 M 9.29 M 8.91 M 9.44 M 10.4 M 10.7 M 12.4 M 15.8 M 17.2 M 23.4 M 38.7 M 52.2 M

Gross Profit

-281 K -494 K 349 K 1.95 M 1.48 M 1.97 M 2.47 M 3.22 M 1.46 M 5.46 M -481 K 14.1 M 29 M

Operating Income

-2.75 M -3.55 M -2.86 M -2.58 M -20.4 M -10.4 M -18.7 M -8.16 M -14.3 M -38.8 M -18.6 M 5.91 M 22 M

Interest Expense

334 K 435 K 542 K 294 K 322 K 451 K 539 K 850 K -1.17 M 786 K -349 K -308 K -255 K

EBITDA

1.83 K -848 K 227 K 216 K -461 K -105 K 189 K -28.8 K -449 K -549 K -6.24 M 8.83 M 23.2 M

Operating Expenses

2.47 M 3.06 M 3.21 M 4.42 M 4.87 M 5.34 M 5.57 M 6.33 M 5.51 M 7.8 M 7.37 M 6.71 M 6.96 M

General and Administrative Expenses

1.47 M 1.89 M 1.65 M 1.82 M 2.29 M 1.95 M 2.02 M 2.27 M 1.9 M 1.72 M 2.4 M 3.31 M 3.72 M

All numbers in USD currency

Quarterly Income Statement China Pharma Holdings

2024-Q3 2024-Q2 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

17.3 M 16.1 M 10.6 M 2.64 M 1.69 M 8.08 M 7.49 M 5 M 4.85 M 4.74 M 47.3 M 46 M 45.6 M 45.6 M 45.6 M 43.6 M 43.6 M 43.6 M 43.6 M 43.6 M 43.6 M 43.6 M 43.6 M 43.6 M 43.6 M 43.6 M 43.6 M 43.6 M 43.6 M 43.6 M 43.6 M 43.6 M 43.6 M 43.6 M 43.6 M 43.6 M 43.6 M 43.6 M 43.6 M 43.6 M 43.6 M 43.6 M 43.6 M 43.6 M 43.6 M 43.6 M 43.6 M 43.6 M 43.6 M 43.6 M 43.5 M 43.5 M 43.5 M 43.5 M

Net Income

-1.12 M -1.44 M - -778 K -593 K -476 K - -791 K -888 K -1.03 M - -827 K -825 K -767 K - -1.01 M 13.1 K -661 K - -701 K -838 K -418 K - -1.86 M -1.01 M -293 K - -2.2 M -2.29 M -967 K - -1.75 M -2.45 M -1.55 M - 2.93 M 1.13 M -4.07 M - -6.33 M -8.64 M -2.39 M - -9.58 M -4.46 M 287 K - 5.86 M 4.57 M 2.81 M - 3.29 M 5.07 M 5.1 M

Revenue

1.1 M 925 K - 1.8 M 1.1 M 1.96 M - 1.97 M 1.61 M 1.6 M - 1.98 M 2.42 M 2.36 M - 2.4 M 3.77 M 1.76 M - 2.38 M 2.57 M 2.93 M - 2.3 M 3.17 M 3.62 M - 3.16 M 2.92 M 3.29 M - 3.13 M 3.54 M 3.64 M - 4.48 M 5.67 M 5.69 M - 5.57 M 6.13 M 7.11 M - 8.12 M 8.03 M 8.25 M - 12.2 M 14.6 M 16.1 M - 21 M 19.6 M 18.1 M

Cost of Revenue

1.62 M 1.94 M - 2.04 M 1.24 M 1.78 M - 2.1 M 1.84 M 1.77 M - 2.28 M 2.34 M 2.09 M - 2.35 M 2.62 M 1.57 M - 2 M 2.41 M 2.27 M - 1.79 M 2.59 M 2.56 M - 2.74 M 2.27 M 2.57 M - 2.78 M 3.06 M 3 M - 3.72 M 4.51 M 4.43 M - 4.06 M 3.71 M 4.45 M - 5.86 M 5.85 M 6.13 M - 8.93 M 10.5 M 10.8 M - 13.5 M 12.3 M 11.2 M

Gross Profit

-520 K -1.02 M - -233 K -147 K 178 K - -138 K -229 K -169 K - -296 K 71 K 273 K - 47.2 K 1.15 M 194 K - 373 K 164 K 657 K - 513 K 579 K 1.05 M - 422 K 648 K 718 K - 350 K 482 K 641 K - 322 K -55.8 K 1.06 M - 1.51 M 2.42 M 2.66 M - 2.24 M 2.15 M -1.57 M - 3.24 M 4.14 M 5.3 M - 7.51 M 7.28 M 6.87 M

Operating Income

-1.09 M -1.39 M - -714 K -456 K -397 K - -689 K -780 K -912 K - -762 K -753 K -696 K - -952 K 75 K -599 K - -645 K -753 K -334 K - -1.93 M -864 K -141 K - -2.06 M -2.13 M -803 K - -1.55 M -2.22 M -1.32 M - 3.19 M 1.44 M -3.76 M - -5.99 M -8.53 M -2.34 M - -2.69 M -4.76 M -3 M - 1.62 M 2.21 M 3.41 M - 5.96 M 5.76 M 5.34 M

Interest Expense

6.84 K - - 6.94 K 138 K 79.4 K - 104 K 110 K 124 K - 64.9 K 72.4 K 71.3 K - 61.1 K 63.1 K 62 K - 67.6 K 97.3 K 86.8 K - 102 K 131 K 129 K - 131 K 142 K 139 K - 214 K 244 K -242 K - 279 K 322 K 314 K - -325 K -113 K -56.4 K - -89.2 K -92 K 82.4 K - -79.5 K -78.5 K -77.5 K - -62.4 K -61.2 K -61.2 K

EBITDA

-493 K -755 K - -83 K 185 K 244 K - -33.3 K -770 K -238 K - 1.61 M 648 K 3.72 K - 1.03 M 1.38 M 56.6 K - 1.62 M 823 K 461 K - 568 K 850 K 721 K - 393 K -503 K 12.8 K - 1.04 M -493 K -464 K - 5.96 M 3.32 M -2.81 M - -4.98 M -7.93 M -2.04 M - -1.65 M -4.06 M -2.96 M - 2.71 M 2.94 M 3.78 M - 7.05 M 6.65 M 5.78 M

Operating Expenses

566 K 376 K - 480 K 310 K 575 K - 551 K 550 K 742 K - 466 K 824 K 969 K - 1 M 1.07 M 794 K - 1.02 M 917 K 991 K - 2.44 M 1.44 M 1.19 M - 2.48 M 2.78 M 1.52 M - 1.9 M 3.05 M 1.96 M - -1.22 M -1.49 M 4.82 M - 7.57 M 10.9 M 5 M - 4.92 M 6.91 M 1.43 M - 1.63 M 1.93 M 1.89 M - 1.55 M 1.67 M 1.53 M

General and Administrative Expenses

345 K 91.9 K - 246 K 112 K 418 K - 277 K 273 K 514 K - 302 K 330 K 409 K - 291 K 322 K 389 K - 334 K 335 K 429 K - 327 K 353 K 492 K - 349 K 612 K 417 K - 294 K 781 K 319 K - 384 K 459 K 472 K - 423 K 383 K 424 K - 373 K 591 K 573 K - 598 K 813 K 676 K - 621 K 987 K 917 K

All numbers in USD currency